References and Notes
1
Macilwain C.
Nature (London)
1993,
365:
378
2
Jones A.
Sugers J.
Walker R.
Clercq E.
J. Med. Chem.
1988,
31:
268
3
Miyasaka T.
Tanaka H.
Baba M.
Hayasaka H.
Walker R.
Balzarini J.
Clercq E.
J. Med. Chem.
1989,
32:
2507
4
Robins R.
Hitchings G.
J. Am. Chem. Soc.
1955,
77:
2267
5 Sato Y, Fujita H, Tagaki H, and Kamoshita K. inventors; Ger. Offen. 2,526,983.
; Chem. Abstr. 1976, 84, 507
6
Meszaros Z.
Knoll J.
Szentmiklosi P.
Hermecz I.
Harvath A.
Nagy G.
Virag S.
Vasvari-Debreczy L.
David A. Hung. Teljes 17,187 (Cl. C07D) 27 Oct. 1979, Appl. 1,673, 25 Jun 1976; 30pp; Chem. Abstr. 1980, 92, 163997u
7a
Itoh T.
Fujii I.
Tomii Y.
Ishikawa I.
Ogura H.
Mizuno Y.
Kawahara N.
J. Heterocycl. Chem.
1987,
24:
1453
7b
Bhuyan P.
Boruah RC.
Sandhu JS.
J. Org. Chem.
1990,
55:
568
7c
Youssif S.
El-Bahaie S.
Nabih E.
J. Chem. Res., Synop.
1999,
112
7d
Koen MJ.
Gready JE.
J. Org. Chem.
1993,
58:
1104
7e
Devi I.
Bhuyan PJ.
Synlett
2004,
283
7f
Ahluwalia VK.
Kumar R.
Khurana K.
Batla R.
Tetrahedron
1990,
46:
3953
7g
Srivastava P.
Saxena AS.
Ram VJ.
Synthesis
2000,
541
7h
Hughes DD.
Bagley MC.
Synlett
2002,
1332
8a
Youssif S.
Assy M.
J. Chem. Res., Synop.
1996,
442
8b
Popp FD.
Catala A.
J. Org. Chem.
1961,
26:
2738
8c
Taylor E.
Cheng C.
J. Org. Chem.
1960,
25:
148
8d
Yoneda F.
Sakuma Y.
Mazumoto S.
Ito R.
J. Chem. Soc., Perkin Trans. 1
1976,
1805
9a
Schell P.
Richards MP.
Hanson K.
Berk SC.
Makara GM.
J. Comb. Chem.
2005,
7:
96
9b
Mont N.
Teixido J.
Borrell JI.
Kappe CO.
Tetrahedron Lett.
2003,
44:
5385
10
Delia TJ.
Baumann M.
Bunker A.
Heterocycles
1993,
35:
1397
11a
Hirota K.
Kitade Y.
Senda S.
Halat MJ.
Watanabe KA.
Fox JJ.
J. Org. Chem.
1981,
46:
846
11b
Su TL.
Huang JT.
Burchanal JH.
Watanabe KA.
Fox JJ.
J. Med. Chem.
1986,
29:
709
11c
Prajapati D.
Sandhu JS.
Synthesis
1988,
342
12a
Taylor EC.
Sawinski F.
J. Org. Chem.
1974,
39:
907
12b
Wamhoff H.
Winfried S.
J. Org. Chem.
1986,
51:
2787
12c
Hirota K.
Benno K.
Yamada Y.
Senda S.
J. Chem. Soc., Perkin Trans. 1
1985,
1137
12d
Sasaki T.
Minamoto T.
Suzuki T.
Suguira T.
J. Am. Chem. Soc.
1978,
100:
2248
13
Billings BK.
Wagner JA.
Cook PD.
Castle RN.
J. Heterocycl Chem.
1975,
12:
1221
14
Wamhoff H.
Muhr J.
Synthesis
1988,
919
15
Reaction of Uracil Amidine 1 with Carbonyl Compounds and Ammonium Acetate under Solvent-Free Conditions and Synthesis of Novel Dihydropyrimido[4,5-
d
]pyr-imidine Derivatives 4.
An equimolar amount of 6-[(dimethylamino)methyl-ene]amino-1,3-dimethyl uracil (0.210 g, 1 mmol), tolualde-hyde (0.123 g, 1 mmol), NH4OAc (0.077 g, 1 mmol) in the presence of AcOH (0.006 g, 0.1 mmol) were mixed well and heated about 2 h at 90 °C. After completion of the reaction (monitored by TLC) the reaction vessel was allowed to cool to r.t. and added 30 mL of cold H2O. The crude product was extracted with EtOAc (3 × 30 mL) and washed with H2O. The combined organic phases were dried over anhyd Na2SO4 and subjected to column chromatography using EtOAc-hexane (1:6) as the eluent to afford the corres-ponding dihydropyrimido[4,5-d]pyrimidine 4a in 90% yield; mp 206-209 °C. Similarly, dihydropyrimido[4,5-d]pyrimidines 4b-i were prepared and characterized as described below.
Compound 4a: IR (KBr): νmax = 3255 (NH), 1687, 1644 (C=O), 1551 (C=N) cm-1. 1H NMR: δ = 3.10 (s, 3 H, NCH3), 3.48 (s, 3 H, NCH3), 2.30 (s, 3 H, CH3), 5.44 (s, 1 H), 6.62-7.28 (m, 5 H, ArH and 1 H, CH=N-). 13C NMR: δ = 161.84 (C-2), 152.70 (C-4), 152.43 (C-8a), 150.99 (C-7), 141.35, 138.84, 129.86, 127.12, 90.53 (C-4a), 52.36 (C-5), 29.76 (C-9), 28.09 (C-10), 21.55 (C-Me). MS: m/z = 285 [M+ + 1]. Anal. Calcd (%) for C15H16N4O2: C, 63.38; H, 5.63; N, 19.72. Found: C, 63.47; H, 5.77; N, 19.65.
Compound 4b: IR (KBr): νmax = 3260 (NH), 1690, 1645 (C=O), 1570 (C=N) cm-1. 1H NMR: δ = 3.24 (s, 3 H, NCH3), 3.51 (s, 3 H, NCH3), 5.60 (s, 1 H), 6.46 (br, 1 H, NH), 7.05-7.61 (m, 5 H, ArH and 1 H, CH=N-). 13C NMR: δ = 160.8 (C-2), 151.4 (C-4), 151.1 (C-8a), 149.2, 140.5, 139.1, 128.1, 126.1, 90.1 (C-4a), 54.1 (C-5), 29.1 (C-9), 275 (C-10). MS: m/z = 271 [M+ + 1]. Anal. Calcd (%) for C14H14N4O2: C, 62.22; H, 5.18; N, 20.74. Found: C, 62.31; H, 5.10; N, 20.82.
Compound 4c: IR (KBr): νmax = 3265 (NH), 1700, 1650 (C=O), 1560 (C=N) cm-1. 1H NMR: δ = 3.20 (s, 3 H, NCH3), 3.62 (s, 3 H, NCH3), 5.55 (s, 1 H), 6.44 (br, 1 H, NH), 7.01-7.65 (m, 4 H, ArH and 1 H, CH=N-). MS: m/z 305 [M+ + 1]. Anal. Calcd (%) for C14H13N4O2Cl: C, 55.26; H, 4.27; N, 18.42. Found: C, 55.31; H, 4.32; N, 18.33.
Compound 4d: IR (KBr): νmax = 3260 (NH), 1695, 1650 (C=O), 1570 (C=N) cm-1. 1H NMR: δ = 3.19 (s, 3 H, NCH3), 3.51 (s, 3 H, NCH3), 3.88 (s, 3 H, OCH3), 5.54 (s, 1 H), 6.47 (br, 1 H, NH), 6.81 (d, 2 H, ArH), 7.26-7.85 (m, 2 H, ArH and 1 H, CH=N-). MS: m/z = 301 [M+ + 1]. Anal. Calcd (%) for C15H16N4O3: C, 60.00; H, 5.33; N, 18.67. Found: C, 60.12; H, 5.41; N, 18.55.
Compound 4e: IR (KBr): νmax = 3255 (NH), 1700, 1650 (C=O), 1560 (C=N) cm-1. 1H NMR: δ = 3.12 (s, 3 H, NCH3), 3.44 (s, 3 H, NCH3), 5.58 (s, 1 H), 6.42 (br, 1 H, NH), 6.95-7.55 (m, 4 H, ArH and 1 H, CH=N-). MS: m/z = 316 [M+ + 1]. Anal. Calcd (%) for C14H13N5O4: C, 53.33; H, 4.12; N, 22.22. Found: C, 53.42; H, 4.23; N, 22.08.
Compound 4f: IR (KBr): νmax = 3260 (NH), 1695, 1655 (C=O), 1560 (C=N) cm-1. 1H NMR: δ = 3.18 (s, 3 H, NCH3), 3.58 (s, 3 H, NCH3), 5.61 (s, 1 H), 6.45 (br, 1 H, NH), 7.05-7.66 (m, 4 H, ArH and 1 H, CH=N-). MS: m/z = 350 [M+ + 1]. Anal. Calcd (%) for C14H13N4O2Br: C, 48.13; H, 3.72; N, 16.04. Found: C, 48.22; H, 3.85; N, 15.94.
Compound 4g: IR (KBr): νmax = 3320 (NH), 1685, 1650 (C=O), 1560 (C=N) cm-1. 1H NMR: δ = 3.20 (s, 3 H, NCH3), 3.60 (s, 3 H, NCH3), 5.45 (s, 1 H), 6.35 (br, 1 H, NH), 6.75 (dd, 1 H), 6.95-7.15 (m, 2 H), 7,65 (s, 1 H, CH=N-). MS: m/z = 277 [M+ + 1]. Anal. Calcd (%) for C12H12N4O2S: C, 52.17; H, 4.35; N, 20.29. Found: C, 52.23; H, 4.26; N, 20.36.
Compound 4h: IR (KBr): νmax = 3310 (NH), 1700, 1655 (C=O), 1560 (C=N) cm-1. 1H NMR: δ = 0.95 (s, 3 H, CH3), 1.25 (m, 6 H) 3.15 (s, 3 H, NCH3), 3.45 (s, 3 H, NCH3), 5.45 (s, 1 H), 6.40 (br, 1 H, NH), 7.65 (s, 1 H, CH=N-). MS: m/z = 251 [M+ + 1]. Anal. Calcd (%) for C12H18N4O2: C, 57.60; H, 7.20; N, 22.40. Found: C, 57.52; H, 7.32; N, 22.47.
Compound 4i: IR (KBr): νmax = 3270 (NH), 1695, 1645 (C=O), 1565 (C=N) cm-1. 1H NMR: δ = 3.22 (s, 3 H, NCH3), 3.55 (s, 3 H, NCH3), 5.50 (s, 1 H), 6.40 (br, 1 H, NH), 6.66-7.65 (m, 7 H, ArH, CH=CH and 1 H, CH=N-). MS: m/z = 297 [M+ + 1]. Anal. Calcd (%): for C16H16N4O2: C, 64.86; H, 5.40; N, 18.92. Found: C, 64.93; H, 5.43; N, 18.83.
16a
Kunieda T.
Witkop B.
J. Am. Chem. Soc.
1971,
93:
3478
16b
Thiellier HPM.
Koomen GJ.
Pandit UK.
Tetrahedron
1977,
33:
1493
16c
Thiellier HPM.
Koomen GJ.
Pandit UK.
Tetrahedron
1977,
33:
2603
16d
Thiellier HPM.
Koomen GJ.
Pandit UK.
Tetrahedron
1977,
33:
2609
16e
Senda S.
Asao T.
Sugiyama I.
Hirota K.
Tetrahedron Lett.
1980,
21:
531
17
Potts KT.
Walsh EB.
J. Org. Chem.
1988,
53:
1199
18
Demoulin A.
Gorissen H.
Hesbain Frisque A.
Ghosez L.
J. Am. Chem. Soc.
1975,
97:
4409
19
Molecular Orbital Theory for Organic Chemists
Streitwieser A.
Wiley;
New York:
1961.
p.115
20a
Prajapati D.
Thakur AJ.
Tetrahedron Lett.
2005,
46:
1433
20b
Gohain M.
Prajapati D.
Sandhu JS.
Synlett
2004,
235:
1179
21a
Groebke K.
Weber L.
Mehlin F.
Synlett
1998,
661
21b
Varma RS.
Kumar D.
Tetrahedron Lett.
1999,
40:
7665
22a
Cope AC.
Hofmann CM.
Wyckoff C.
Hardenbergh E.
J. Am. Chem. Soc.
1941,
63:
3452
22b
Tanemura K.
Suzuki T.
Nishida Y.
Satsumabayashi K.
Horagushi T.
Chem. Commun.
2004,
470
23a
Deng X.
Mani NS.
Org. Lett.
2006,
8:
269
23b
Xiong X.
Bagley MC.
Chapaneri K.
Tetrahedron Lett.
2004,
45:
6121
24a
Cave GWV.
Raston CL.
Chem. Commun.
2000,
2199
24b
Li W.
Wayne GS.
Lallaman JE.
Chang SJ.
Wittenberger SJ.
J. Org. Chem.
2006,
71:
1725
25
Xia JJ.
Wang GW.
Synthesis
2005,
2379
26
Fan XS.
Li YZ.
Zhang XY.
Qu GR.
Wang JJ.
Hu XY.
Heteroat. Chem.
2006,
17:
382
27a
Risitano F.
Grassi G.
Foti F.
Moraci S.
Synlett
2005,
1633
27b
Yadav LDS.
Rai VK.
Tetrahedron Lett.
2006,
47:
395
27c
Yadav LDS.
Yadav S.
Rai VK.
Green Chem.
2006,
8:
455
28
Prasad AS.
Sandhu JS.
Baruah JN.
J. Heterocycl. Chem.
1984,
21:
1657